Apollomics, Inc. (APLMW) Stock Ticker
Market factors today
Unlock the full APLMW picture
About Apollomics, Inc.
Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.
APLMW stock facts
| Ticker symbol | APLMW |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $172.9M |
| CEO | Hung-Wen Chen |
| Employees | 14 |
| Headquarters | Foster City, CA, US |
| IPO date | 2023-03-30 |
| Website | www.apollomicsinc.com |
What you can see for APLMW on Tickr
Live APLMW price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the APLMW report.
Rankings
FAQ
What is the ticker symbol for Apollomics, Inc.?
The ticker symbol for Apollomics, Inc. is APLMW, listed on the NASDAQ Capital Market.
What is APLMW?
Apollomics, Inc. functions as a clinical-phase biotechnology enterprise, concentrating its efforts on discovering and advancing novel cancer treatments to meet crucial, underserved patient requirements. The company was co-founded by Liang Yu Guo and Sanjeev Redkar in 2015, with its main operations based in Foster City, California.